Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.235 USD | -1.98% | -1.20% | -32.88% |
09/04 | Biodesix, Inc. announced that it has received $34.999422 million in funding | CI |
05/04 | Top Midday Decliners | MT |
Sales 2024 * | 65.25M 5.44B | Sales 2025 * | 79.05M 6.59B | Capitalization | 140M 11.7B |
---|---|---|---|---|---|
Net income 2024 * | -39M -3.25B | Net income 2025 * | -32M -2.67B | EV / Sales 2024 * | 2.15 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
-3.09
x | P/E ratio 2025 * |
-4.05
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.47% |
Latest transcript on Biodesix, Inc.
1 day | -1.98% | ||
1 week | -1.20% | ||
Current month | -13.64% | ||
1 month | -14.24% | ||
3 months | -37.31% | ||
6 months | -11.15% | ||
Current year | -32.88% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 01/11/01 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 01/08/01 |
Jack Schuler
BRD | Director/Board Member | 83 | 01/12/01 |
Jon Kayyem
BRD | Director/Board Member | 60 | 06/21/06 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.235 | -1.98% | 13,931 |
25/24/25 | 1.26 | 0.00% | 15,737 |
24/24/24 | 1.26 | -1.56% | 7,101 |
23/24/23 | 1.28 | -0.78% | 36,906 |
22/24/22 | 1.29 | +3.20% | 48,595 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.88% | 140M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- BDSX Stock